Literatur
- 1
Allgayer H, Tillmann T, Hombach A. et al .
Aminosalicylate und Aspirin bei Kolonkarzinomen:
vom Entzündungshemmer zum Tumorprophylaktikum?.
Z
Gastroenterol.
2000;
38
963
- 2
Aziz Q, Thompson D G.
Brain-gut
axis in health and disease.
Gastroenterology.
1998;
114
569
- 3
Bayless T M, Bayless J A, O`Brien J. et al .
Crohn`s disease: Long-term disease
activity suppression with multiple drug therapy.
Gastroenterology.
1991;
100
A196
- 4
Bayless T M.
Inflammatory
bowel disease and irritable bowel syndrome.
Med Clin North
Am.
1990;
49
21
- 5
Best W R, Becktel J M, Singleton J W.
Re-derived
values of the eight coefficients of the Crohn`s disease
activity index (CDAI).
Gastroenterology.
1979;
77
843
- 6
Bjarnason I, Peters T J.
Intestinal
permeability, non steroidal and anti-inflammatory drug enteropathy
and inflammatory bowel disease: An overview.
Gut Festschrift.
1989;
30
22
- 7
Bouhnik Y, Lemann M, Mary J Y. et al .
Long-term follow-up of patients with Crohn`s
disease treated with azathioprine or 6-mercaptopurine.
Lancet.
1996;
347
215
- 8
Brentnall T A, Haggitt R C, Rabinovitch P S. et al .
Risk and natural history of colonic neoplasia
in patients with primary sclerosing cholangitis and ulcerative colitis.
Gastroenterology.
1996;
110
331
- 9
Cameron J L, Hamilton S R, Coleman J. et al .
Patterns of ileal recurrence in Crohn`s
disease: A prospective randomised study.
Ann Surg.
1992;
215
546
- 10
Camma C, Giunta M, Rosselli M. et al .
Mesalamine
in the maintenance treatment of Crohn`s disease: A meta-analysis
adjusted for confounding variables.
Gastroenterology.
1997;
113
1465
- 11
Cosnes J, Carbonnel F, Beaugerie L. et al .
Effects of cigarette smoking on the long-term
course of Crohn`s disease.
Gastroenterology.
1996;
110
424
- 12
D`Haens G, Rutgeerts P.
Postoperative recurrence
of Crohn`s disease: Pathophysiology and prevention.
Inflamm
Bowel Dis.
1999;
5
295
- 13
Egan L J, Sandborn W J, Tremaine W J.
Clinical
outcome following treatment of refractory and fistulizing Crohn`s
disease with intravenous cyclosporine.
Am J Gastroenterol.
1998;
93
442
- 14
Ekbom A, Helmick G, Zack M. et al .
Ulcerative
colitis and colorectal cancer. A population based study.
N
Engl J Med.
1990;
323
1228
- 15
Farmer R G, Easley K A, Rankin G B.
Clinical
patterns, natural history, and progression of ulcerative colitis - A
long-term follow-up of 1116 patients.
Dig Dis Sci.
1993;
38
1137
- 16
Fazio V W, Marchetti F, Church J. et al .
Effect of resection margins on the recurrence
of Crohn`s disease in the small bowel.
Ann Surg.
1996;
224
563
- 17
Floren C H, Benoni C, Willen R.
Histologic
and colonoscopic assessment of disease extension in ulcerative colitis.
Scand
J Gastroenterol.
1987;
22
459
- 18
Giardiello F, Gurbuz A K, Bayless T M. et al .
Colorectal cancer in ulcerative colitis:
Survival in patients with and without colorectal cancer symptoms.
Inflamm
Bowel Dis.
1996;
2
6
- 19
Greenstein A J, Janowitz H D, Sachar D B.
The
extraintestinal complications of Crohn`s disease and ulcerative
colits. A study of 700 patients.
Medicine.
1976;
55
401
- 20
Gumaste V, Sachar D B, Greenstein A J.
Benign
and malignant colorectal strictures in ulcerative colitis.
Gut.
1992;
33
938
- 21
Hunt L E, Eichenberger M R, Petras R. et al .
Use of microsatellite marker in predicting
dysplasia in ulcerative colitis.
Arch Surg.
2000;
135
582
- 22
Janowitz H D, Bodian C.
The placebo reponse and
the »natural history « of inflammatory bowel disease.
Inflamm
Bowel Dis.
2001;
7
64
- 23
Karlen P, Lofberg R, Brostrom O. et al .
Increased risk of cancer in ulcerative
colitis: a population-based cohort study.
Am J Gastroenterol.
1999;
94
1047
- 24
Kartheuser A H, Dozios R, LaRusso N F. et al .
Comparison of surgical treatment of ulcerative
colitis associated with primary sclerosing cholangitis: Ileal pouch
anal anastomosis versus Brooke ileostomy.
Mayo Clin Proc.
1996;
71
748
- 25
Keller R, Fischbach W.
Kolorektales Karzinomrisiko
bei chronisch entzündlichen Darmerkrankungen.
Leber
Magen Darm.
2000;
30
14
- 26
Korelitz B I.
The
role of liquid diet in the management of mall bowel Crohn`s
disease.
Inflamm Bowel Dis.
2000;
6
66
- 27
Langholz E, Munkholm P, Davidsen M. et al .
Changes in extent of ulcerative colitis - A
study on the course and prognostic factors.
Scand J Gastroenterol.
1996;
31
260
- 28
Langholz E, Munkholm P, Davidsen M. et al .
Course of ulcerative colitis: Analysis
of changes in disease activity over the years.
Gastroenterology.
1991;
100
350
- 29 Lashner B A. Clinical
features, laboratory findings, and course of Crohn`s disease. Philadelphia,
W.B. Saunders Co In Kirsner JB (ed.): Inflammatory
bowel disease, 5th ed 2000: 305
- 30
Levenstein S, Prantera C, Varva V. et al .
Stress and exacerbation in ulcerative colitis:
a prospective study of patients enrolled in remission.
Am
J Gastroenterol.
2000;
95
1213
- 31
Lewis J D, Deren J J, Lichtenstein G R.
Cancer
risk in patients with inflammatory bowel disease.
Gastroenterol
Clin North Am.
1999;
28
459
- 32
Mary J, Modigliani R. Groupe d`etudes therapeutiques des affections inflammatoires
du tube digestif (GETAID) .
Development and validation
of an endoscopic index of the severity for Crohn`s disease:
A prospective multicenter study.
Gut.
1989;
30
983
- 33
O`Donoghue D P, Dawson A M, Powell-Tuck J. et al .
Double-blind withdrawal trial of azathioprine
as maintenance treatment for Crohn`s disease.
Lancet.
1978;
2
955
- 34
Odze R D.
Adenomas
and adenoma-like DALMs in chronic ulcerative colitis: a clincal,
pathological and molecular review.
Am J Gastroenterol.
1999;
94
1746
- 35
Penna C, Dozois R, Tremaine W. et al .
Pouchitis
after ileal pouch-anal anastomosis for ulcerative colitis occurs
with increased frequency in patients with associated primary sclerosing
cholangitis.
Gut.
1996;
38
234
- 36 Picco M F, Bayless T h. Prognostic
considerations in idiopathic inflammatory bowel disease. Philadelphia,
W.B.Saunders Co In Kirsner JB(ed.):Inflammatory
Bowel Disease, 5th ed 2000: 765
- 37
Polito L M, Rees R C, Childs B. et al .
Preliminary evidence for genetic anticipation
in Crohn`s disease.
Lancet.
1996;
347
798
- 38
Present D H, Rutgeerts P, Targan S. et al .
Infliximab for the treatment of fistulas
in patients with Crohn`s disease.
N Engl J Med.
1999;
340
1398
- 39
Russel M G, Dorant E, Brummer J M. et al .
Appendectomy and the risk of developing
ulcerative colitis or Crohn`s disease: Results of a large case
control study.
Gastroenterology.
1997;
113
377
- 40
Sandborn W J.
Preliminary
report on the use of oral tacrolimus (FK506) in the treatment of
complicated proximal small bowel and fistulizing Crohn`s
disease.
Am J Gastroenterol.
1997;
92
876
- 41
Shetty K, Rybicki L, Brzezinski A. et al .
The risk for cancer or dysplasia in ulcerative
colitis patients with primary sclerosing cholangitis.
Am J
Gastroenterol.
1999;
94
1643
- 42
Sigel J E, Petras R E, Lashner B A. et al .
Intestinal adenocarcinoma in Crohn`s
disease: a report of 30 cases with a focus on coexisting dysplasia.
Am
J Surg Pathol.
1999;
23
651
- 43 Spencer D R, Mayberry J F. Clinical
indices in inflammatory bowel. London, Churchill In
Allan RN, Rhodes JM, Hanauer SB, et al.: (eds.): Inflammatory bowel
Diseases, 3rd ed 1998: 335
- 44
Timmer A, Sutherland L R, Martin F. et al .
Oral contraceptive use and smoking are
risk factors for relapse in Crohn`s disease.
Gastroenterology.
1998;
114
1143
- 45
Truelove S C, Witts L J.
Cortisone in
ulcerative colitis - Final report on a therapeutic trial.
BMJ.
1955;
3
1041
- 46
Vieth M, Stolte M, Mueller E. et al .
Bioptical
differential diagnosis of adenomas, dysplasias and carcinomas in
patients with ulcerative colitis.
Leber Magen Darm.
2000;
30
125
- 47
Walmsley R S, Gillen G D, Allan R D.
Prognosis
and management of crohn`s disease in the over 55 age group.
Postgrad
Med J.
1997;
73
225
- 48
Ziv Y, Fazio V W, Sirimarco M T. et al .
Incidence,risk
factors and treatment of dysplasia in the anal transition zone after
ileal pouch-anal anastomosis.
Dis Colon Rectum.
1994;
37
1281
Prof. Dr. F. Hartmann
Katharina-Kasper-Kliniken (St.Marienkrankenhaus)
Richard-Wagner-Straße 14
60318 Frankfurt
069/1563134
F.Hartmann@em.univ.Frankfurt.de
